R Chin
University of Melbourne(AU)Austin Hospital(AU)Quest Clinical Research (United States)(US)Vertex Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research, T-cell and B-cell Immunology, Hepatitis C virus research
Most-Cited Works
- → A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy(2005)68 cited
- → The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4+ T-cell epitope in human interferon-β(2004)44 cited
- → Characterization of a CC49-Based Single-Chain Fragment−β-Lactamase Fusion Protein for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)(2006)39 cited
- → A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120(1992)38 cited
- → Human population-based identification of CD4+ T-cell peptide epitope determinants(2003)17 cited
- → Construction and optimization of a CC49-Based scFv-β-lactamase fusion protein for ADEPT(2006)15 cited